Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

OSCAR-collagen signaling in monocytes plays a proinflammatory role and may contribute to the pathogenesis of rheumatoid arthritis.

Schultz HS, Guo L, Keller P, Fleetwood AJ, Sun M, Guo W, Ma C, Hamilton JA, Bjørkdahl O, Berchtold MW, Panina S.

Eur J Immunol. 2016 Apr;46(4):952-63. doi: 10.1002/eji.201545986. Epub 2016 Feb 9.

2.

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC.

Cancer Cell. 2008 Nov 4;14(5):408-19. doi: 10.1016/j.ccr.2008.10.011. Erratum in: Cancer Cell. 2008 Dec 9;14(6):494. Cancer Cell. 2011 Jan 18;19(1):154.

3.

Next generation adoptive immunotherapy--human T cells as carriers of therapeutic nanoparticles.

Mortensen MW, Kahns L, Hansen T, Sorensen PG, Björkdahl O, Jensen MR, Gundersen HJ, Bjørnholm T.

J Nanosci Nanotechnol. 2007 Dec;7(12):4575-80.

PMID:
18283847
4.

Functionalization and cellular uptake of boron carbide nanoparticles. The first step toward T cell-guided boron neutron capture therapy.

Mortensen MW, Björkdahl O, Sørensen PG, Hansen T, Jensen MR, Gundersen HJ, Bjørnholm T.

Bioconjug Chem. 2006 Mar-Apr;17(2):284-90.

PMID:
16536457
5.

CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.

Song X, Krelin Y, Dvorkin T, Bjorkdahl O, Segal S, Dinarello CA, Voronov E, Apte RN.

J Immunol. 2005 Dec 15;175(12):8200-8.

6.

Preparation and characterization of Boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy.

Mortensen MW, Sørensen PG, Björkdahl O, Jensen MR, Gundersen HJ, Bjørnholm T.

Appl Radiat Isot. 2006 Mar;64(3):315-24. Epub 2005 Nov 15.

PMID:
16290943
7.

Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.

Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, Benharroch D, Shendler Y, Bjorkdahl O, Segal S, Dinarello CA, Apte RN.

J Immunol. 2003 Dec 15;171(12):6448-56.

8.

Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues.

Bjorkdahl O, Barber KA, Brett SJ, Daly MG, Plumpton C, Elshourbagy NA, Tite JP, Thomsen LL.

Immunology. 2003 Oct;110(2):170-9.

10.

Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.

Apte RN, Dvorkin T, Song X, Fima E, Krelin Y, Yulevitch A, Gurfinkel R, Werman A, White RM, Argov S, Shendler Y, Bjorkdahl O, Dohlsten M, Zoller M, Segal S, Voronov E.

Adv Exp Med Biol. 2000;479:277-88. Review. No abstract available.

PMID:
10897428
11.

Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product.

Björkdahl O, Akerblad P, Gjörloff-Wingren A, Leanderson T, Dohlsten M.

Immunology. 1999 Jan;96(1):128-37.

12.

Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo.

Björkdahl O, Wingren AG, Hedhund G, Ohlsson L, Dohlsten M.

Cancer Immunol Immunother. 1997 Jul;44(5):273-81.

PMID:
9247562
13.

Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release.

Wingren AG, Björkdahl O, Labuda T, Björk L, Andersson U, Gullberg U, Hedlund G, Sjögren HO, Kalland T, Widegren B, Dohlsten M.

Cell Immunol. 1996 May 1;169(2):226-37.

PMID:
8620550
14.

A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma.

Labuda T, Lando P, Björkdahl O, Kalland T, Vessella R, Hedlund G, Eriksson H, Sjögren HO, Dohlsten M.

Int Immunol. 1995 Sep;7(9):1425-32.

PMID:
7495750

Supplemental Content

Loading ...
Support Center